For construction of GFP reporter plasmids
For construction of complemented plasmids
For detection of gene expression by qPCR
For nucleotides amplification for EMSA
SA-spx-pro-short-F TAATTATCATTATAACAGTATTTCTTAAAAATGTAAG SA-spx-pro-short-R2 CATTAAAATTAAATGAGAAAAACCTA SA-arl-pro-short-F GAGTTAATAAATAATTAATGATTGTAGCT A ~200 bp fragment containing the putative mgrA promoter or spx promoter region was amplified from the genomic DNA of USA300 TCH1516 strain and inserted into upstream of the GFP gene in pCM29. The resulting plasmids pCM29-mgrA and pCM29-spx were transformed into USA300 and ΔarlRS strains by electroporation. The intensity of GFP fluorescence indicating either spx or mgrA expression was monitored with excitation at 480 nm and emission at 515 nm. The experiment was performed in quadruplicates and was repeated at least once. The representative result at 4 h was shown as mean values ± standard derivations.
Supplementary

Supplementary Figure 2 Supplementary Figure 2. Inhibition of ArlS kinase activity by oritavancin
(a) Detection of ATPase activity of the purified recombinant cytoplasmic domain of ArlS protein (ArlS') using the Kinase-Glo TM Luminescent Kinase Assay. Briefly, 1.8 μg and 3.6 μg purified ArlS' was incubated with 4 μM ATP in 50 μl reaction buffer [40 mM Tris (pH 7.5), 20 mM MgCl2 and 0.1 mg/ml BSA] for 30 min at room temperature. Afterwards, 50 μl Kinase-Glo TM Reagent was added, mixed and kept at room temperature for 10 min before the final recording of the luminescence (RLU). The reactions were carried out in solid black, flat-bottomed 96-well plates.
(b) Measurement of the inhibitory effect of oritavancin on the ArlS' ATPase activity.
In brief, 3 μg purified ArlS' protein was pre-incubated with a series of dilutions of oritavancin (0.195, 0.39, 0.78, 1.56, 3.13, 6.25, 12.5, 25 and 50 μM) in reaction buffer at 4℃ for 30 min, then 4 μM ATP was added and incubated for 30 min at room temperature. The dose-dependent inhibition of oritavancin on the ArlS' ATPase activity was measured with the Kinase-Glo TM Luminescent Kinase Assay, and the IC50 value of oritavancin was calculated with the logistic regression fit using the Origin 7.0 software. GelRed.
